Lv1
72 积分 2022-04-28 加入
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
2天前
已完结
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
2天前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
1个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
1个月前
已完结
iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma
1个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
1个月前
已完结
Review of Systemic Lupus Erythematous
2个月前
已完结
Emerging biologic therapies for systemic lupus erythematosus
2个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
2个月前
已关闭
Childhood-Onset Systemic Lupus Erythematosus
2个月前
已完结
皖公网安备34019202002308
